SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
785First, did anyone listen CC? Was there discussion about mechanism/reasons for laMiljenko Zuanic-3/31/2003
784<i>The antibody-neg pts look pretty good. </i> So one question is wBiomaven-3/31/2003
783Wow. I find this surprising. REGN's 10k, filed today, includes as a subseqkeokalani'nui-3/31/2003
782my goodness if this is correct- is it saying that after takng the drug that therMadharry-3/31/2003
781The antibody thing...is it fair to ask what was or should have been previously kkeokalani'nui-3/31/2003
780It's bad certainly, but if I were grossly overweight I would try and hope I A.J. Mullen-3/31/2003
779Even the Novartis deal is slightly tarnished now - <i>Novartis will purchnigel bates-3/31/2003
778CATASTROFE, is my view! :( MiljenkoMiljenko Zuanic-3/31/2003
777Both primary endpoints are met. But if the pre-opening Ask is right, the resultquidditch-3/31/2003
776<<How will REGN repay loan to NVS (+150 millions after PIII) if REGN burnsrkrw-3/29/2003
775One more thing. At Lehman conference Schleifer indicate that IL-1 Trap deal is Miljenko Zuanic-3/29/2003
774<<I took that to imply that REGN expects its own capacity will be needed tMiljenko Zuanic-3/28/2003
773>But for the life of me, I can't make the link between NVS doing the commfred hayes-3/28/2003
772rkrw, so it would seem. According to a Reuters story I read when out of town, tquidditch-3/28/2003
771Indeed, excellent deal for PIIa candidate, 50% of drug economic stay at REGN. TMiljenko Zuanic-3/28/2003
770Undoubtedly speculation going on about axokine phase III results, which are experkrw-3/28/2003
769Can someone explain how this Novartis deal has such a negative impact?rainman-3/28/2003
768TARRYTOWN, N.Y.--(BUSINESS WIRE)--March 28, 2003--Regeneron Pharmaceuticals, Incnigel bates-3/28/2003
767Missing ligand for CNTFR. Endocrinology Vol. 144, No. 4 1202-1210 Copyright Miljenko Zuanic-3/15/2003
766Axokine is ~70% of the current valuation, excluding cash. Targhet price? Last tMiljenko Zuanic-3/15/2003
765How much does axokine account for the current valuation of the company? If the rainman-3/15/2003
764<<The reduced bowel control associated with the pills must be a factor.>Miljenko Zuanic-3/14/2003
763That seems very thorough. Thanks. Increased retention rates bears on the disA.J. Mullen-3/14/2003
762For the first time analyst at LB give up on Axokine safety issue (after two yearMiljenko Zuanic-3/14/2003
761Thanks to friend I got latest Lehman Brother REGN report. Drug Baseline mean wMiljenko Zuanic-3/14/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News